
AI vs. Daffodils: Crafting a Cheaper Alzheimer’s Drug
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.
A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
Walk through the various steps that occur as a person participates in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) project.
Researchers found the walls of the brain’s small arteries are also affected in Alzheimer’s, reducing blood flow. Learn about this new treatment target.
Find out how two biomarkers in saliva diagnose pain in dementia, effectively and non-invasively.
VIDEO+ARTICLE: Kenneth S. Kosik traced an Alzheimer’s gene mutation to a 16th century founder. See him solve this puzzle of the past and show why this can help the future.
In “SUNDOWNING SYNDROME,” people with dementia show high levels of anxiety, agitation, overactivity and delirium. It typically occurs in late afternoon and evening, before their normal time to go to bed. Learn how brain biology explains “sundowning.”
Lecanemab, the newest Alzheimer’s drug, is getting a boost by focusing ultrasound waves on the blood-brain barrier. Learn more about this next step in delivering better Alzheimer’s treatments.
Age does not protect you from love, but love to some extent protects you from age.
How can siblings avoid conflict while caring for aging parents? This Resource Guide can help.
New Test Provides Less Invasive Option, Reduces Reliance on PET Scans and Increases Diagnosis Accessibility
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.